Conduit Pharmaceuticals Inc.
CDT
$0.6201
-$0.16-20.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.41M | -6.46M | -5.38M | -3.55M | 245.00K |
| Total Depreciation and Amortization | 452.00K | 5.00K | -- | -- | -- |
| Total Amortization of Deferred Charges | 786.00K | 143.00K | -- | -- | -- |
| Total Other Non-Cash Items | -230.00K | 2.42M | 3.27M | 1.40M | -2.36M |
| Change in Net Operating Assets | -2.42M | 1.90M | 601.00K | -201.00K | -2.69M |
| Cash from Operations | -3.81M | -2.00M | -1.51M | -2.36M | -4.80M |
| Capital Expenditure | 0.00 | -41.00K | -10.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.00K | 137.00K | -214.00K | -- | 497.00K |
| Cash from Investing | 85.00K | 96.00K | -224.00K | -- | 497.00K |
| Total Debt Issued | 1.48M | 1.74M | -- | -- | -493.00K |
| Total Debt Repaid | -776.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 3.39M | 1.00K | 113.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 113.00K | -- | -- | -- | 80.00K |
| Cash from Financing | 4.21M | 1.74M | 113.00K | -- | -414.00K |
| Foreign Exchange rate Adjustments | 1.00K | 11.00K | -1.00K | -27.00K | 304.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 483.00K | -148.00K | -1.63M | -2.38M | -4.42M |